| Literature DB >> 32300598 |
Mengyan Chen1, Mingxia Ji1, Tiejiang Chen1, Xiaofei Hong2, Yian Jia1.
Abstract
The association between alcohol consumption and venous thromboembolism (VTE) risk has been investigated by various observational studies with inconsistent results. We examined this association by performing a meta-analysis of prospective studies. A comprehensive literature search was carried out in the PubMed, EMBASE, and Web of Science from its inception to February 2020. Pooled effect estimates were calculated using a random effect model. Ten prospective studies (14 cohorts) were included in this meta-analysis with a total of 441,128 individuals and 10,221 VTE cases. Overall, the highest consumption of alcohol was not associated with the VTE risk compared with the lowest group [relative risk (RR), 0.96 (95% CI, 0.89-1.04), P = 0.293]. No obvious heterogeneity of RRs was observed across these studies (P = 0.249 for heterogeneity, I 2 = 18.8%). Egger's and Begg's tests showed no evidence of publication bias (Egger, P = 0.443; Begg, P = 0.730). In the subgroup analysis by sex, a borderline significant association between alcohol consumption and VTE risk was observed in women [RR, 0.91 (95% CI, 0.82-1.00)]. In the dose-response analysis, we observed a linear decrease in VTE risk with increasing alcohol intake (P = 0.634 for nonlinearity). However, the reduced risk was not statistically significant. In conclusion, the results from this meta-analysis suggest that alcohol intake is not related with the risk of VTE. Further large well-designed cohort studies are warranted to investigate a potential protective role of alcohol against VTE in women.Entities:
Keywords: alcohol drinking; cohort; meta-analysis; pulmonary embolism; venous thromboembolism
Year: 2020 PMID: 32300598 PMCID: PMC7145405 DOI: 10.3389/fnut.2020.00032
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Detailed process of literature search and study selection.
Main characteristic of the included studies.
| Johansson et al. ( | Norway | Women | 54,632 | 944 | 30–60 | Questionnaire | 13.9 (mean) | ≥2.13 standard drinks/week vs. <0.09 standard drinks/week | VEINS | Age, BMI, hypertension, smoking, education, and cancer |
| Johansson et al. ( | Norway | Men | 53,393 | 1,110 | 30–61 | Questionnaire | 13.10 (mean) | ≥4.84 standard drinks/week vs. <0.94 standard drinks/week | VEINS | Age, BMI, hypertension, smoking, education, and cancer |
| Gaborit et al. ( | Denmark | Women | 28,169 | 251 | 50–64 | Questionnaire | 10.2 (median) | ≥21 standard drinks/week vs. 0.1–3.9 standard drinks/week | Danish Diet, Cancer, and Health Study | Age, BMI, smoking, and women's use of HRT, physical activity, education, years in school, diet |
| Gaborit et al. ( | Denmark | Men | 26,365 | 352 | 50–64 | Questionnaire | 10.2 (median) | ≥21 standard drinks/week vs. 0.1–3.9 standard drinks/week | Danish Diet, Cancer, and Health Study | Age, BMI, smoking, physical activity, education, years in school, diet |
| Varraso et al. ( | United States | Women | 80,263 | 1,540 | 30–55 | Questionnaire | 1984–2008 | NR | NHS | Age, physical activity, BMI, total caloric intake, smoking, race, spouse's educational attainment, parity, menopausal status, NSAIDs use, warfarin use, multivitamin supplement use, hypertension, CHD, and rheumatologic disease |
| Varraso et al. ( | United States | Men | 49,238 | 1,352 | 40–75 | Questionnaire | 1986–2008 | NR | HPFS | Age, physical activity, BMI, total caloric intake, smoking, race, NSAIDs use, warfarin use, multivitamin supplement use, hypertension, CHD, and rheumatologic disease |
| Wattanakit et al. ( | United States | Both | 15,340 | 468 | 45–64 | Interview | 15.5 (mean) | 100 vs. 0 g/week | ARIC | Age, race, ARIC field center, sex, and BMI |
| Hansen-Krone et al. ( | Norway | Both | 26,662 | 460 | 25–97 | Questionnaire | 12.5 (median) | ≥7 vs. <1 U/week | The Tromsø Study | Age, sex, BMI, smoking, diabetes, cancer, history of CVD, education, and physical activity |
| Holst et al. ( | Denmark | Women | 10,153 | 524 | ≥20 | Questionnaire | 19.5 (median) | NR | Copenhagen City Heart Study | Age and calendar time |
| Holst et al. ( | Denmark | Men | 8,801 | 445 | ≥20 | Questionnaire | 19.5 (median) | NR | Copenhagen City Heart Study | Age and calendar time |
| Lindqvist et al. ( | Sweden | Women | 24,098 | 312 | 25–64 | Questionnaire | 11 (mean) | ≥15 g/day vs. No. | MISS study | Age, cancer, parity, smoking, oral contraceptives use, present regular exercise, and BMI |
| Lutsey et al. ( | United States | Women | 37,393 | 1,950 | 55–69 | Questionnaire | 19 (median) | ≥7 servings/week vs. 0 servings/week | IWHS | Age, kcal, education, smoking, and physical activity |
| Glynn and Rosner ( | United States | Men | 18,662 | 358 | 40–84 | Questionnaire | 20.1 (median) | NR | Physicians' Health Study | NR |
| Pahor et al. ( | United States | Both | 7,959 | 155 | ≥68 | Interview | 48,038 person-years | ≥1 ounce/day vs. none | EPESE | Age, gender, physical disability, BMI, heart attack, number of hospital admissions in past year, and use of coumarin, diuretics, and corticosteroids |
No., number; BMI, body mass index; NR, not reported; NSAIDs, nonsteroidal anti-inflammatory drugs; CHD, coronary heart disease; CVD, cardiovascular disease; VEINS, Venous thromboEmbolism In Northern Sweden; NHS, Nurses' Health Study; HPFS, Health Professionals Follow-Up Study; ARIC, Atherosclerosis Risk in Communities; MISS, Melanoma Inquiry of Southern Sweden; IWHS, Iowa Women's Health Study; EPESE, Established Populations for Epidemiologic Studies of the Elderly.
Figure 2A forest plot showing risk estimates estimating the association between alcohol consumption and venous thromboembolism risk.
Figure 3Sensitivity analysis was performed by removing each study in turn and repeating the pooled relative risk estimates.
Figure 4A funnel plot of studies assessing incident venous thromboembolism in highest alcohol consumers compared with the lowest alcohol consumers.
Stratified analysis of the association between alcohol intake and risk for venous thromboembolism.
| Total | 14 | 0.96 | 0.293 | 16.00 | 18.8 | 0.249 |
| Europe | 8 | 0.97 | 0.701 | 14.43 | 51.5 | 0.044 |
| North America | 6 | 0.93 | 0.178 | 1.08 | 0.0 | 0.956 |
| Male | 5 | 1.02 | 0.766 | 9.04 | 55.8 | 0.060 |
| Female | 6 | 0.91 | 0.056 | 2.00 | 0.0 | 0.850 |
| >500 | 6 | 0.96 | 0.442 | 9.53 | 47.5 | 0.090 |
| ≤500 | 8 | 0.97 | 0.607 | 6.45 | 0.0 | 0.488 |
| >2010 | 8 | 0.98 | 0.575 | 7.50 | 6.7 | 0.379 |
| ≤2010 | 6 | 0.93 | 0.399 | 7.89 | 36.6 | 0.162 |
RR, relative risk; CI, confidence interval.
Figure 5The dose–response association between alcohol intake (grams per day) and venous thromboembolism risk. The solid line and the long dash line represent the estimated risk estimates and their 95% CIs. Short dash line represents the linear relationship.